IP Library Granted Patent US 10,371,692
Granted Patent B2
US 10,371,692 · App. 15/488,432 · Granted Aug 6, 2019

Systems for forming a nanopore in a lipid bilayer

Inventors: Roger J. A. Chen (Saratoga, CA); Randy Davis (Pleasanton, CA)
Assignee: GENIA TECHNOLOGIES, INC.
G01N33/48721B81B1/00G01N15/12G01N15/1218B82Y5/00C12Q1/6869
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,371,692
App. No.
15/488,432
Granted
Aug 6, 2019
Kind
B2
Abstract

A method of forming a nanopore in a lipid bilayer is disclosed. A nanopore forming solution is deposited over a lipid bilayer. The nanopore forming solution has a concentration level and a corresponding activity level of pore molecules such that nanopores are substantially not formed un-stimulated in the lipid bilayer. Formation of a nanopore in the lipid bilayer is initiated by applying an agitation stimulus level to the lipid bilayer. In some embodiments, the concentration level and the corresponding activity level of pore molecules are at levels such that less than 30 percent of a plurality of available lipid bilayers have nanopores formed un-stimulated therein.

Claims (39)

1. A system for forming a nanopore in a lipid bilayer, comprising:

a chamber containing a nanopore forming solution, wherein the nanopore forming solution is deposited over a lipid bilayer, the nanopore forming solution having a concentration level and a corresponding activity level of pore molecules such that nanopores are preferentially inserted via an active mechanism that depends on a voltage stimulus waveform applied across the lipid bilayer over a passive mechanism that depends on a self-assembly process; and

a processor programmed to:

control a voltage source to initiate formation of a nanopore in the lipid bilayer, wherein initiating formation of a nanopore comprises applying the voltage stimulus waveform having a predetermined duration to the lipid bilayer.

2. The system of claim 1 , wherein the concentration level and the corresponding activity level of pore molecules such that nanopores are substantially not formed in the lipid bilayer in a self-assembly process comprise a concentration level and a corresponding activity level of pore molecules such that approximately less than 30 percent of a plurality of lipid bilayers have nanopores formed un-stimulated therein.

3. The system of claim 1 , wherein the processor is further programmed to:

detect whether a nanopore has been formed in the lipid bilayer; and

in the event that a nanopore is not detected, iteratively initiate formation of a nanopore in the lipid bilayer, comprising:

controlling the voltage source to increase the amplitude of the voltage stimulus waveform applied to the lipid bilayer; and

detecting whether a nanopore has been formed in the lipid bilayer.

4. The system of claim 3 , wherein the iteratively initiating formation of a nanopore in the lipid bilayer is repeated until formation of a nanopore is detected.

5. The system of claim 3 , wherein the iteratively initiating formation of a nanopore in the lipid bilayer is repeated until damage to the lipid bilayer is detected.

6. The system of claim 3 , wherein the iteratively initiating formation of a nanopore in the lipid bilayer is repeated until the voltage stimulus waveform has reached a predetermined maximum threshold.

7. The system of claim 3 , wherein the detection of whether a nanopore has been formed in the lipid bilayer comprises detecting a change in an electrical property of the lipid bilayer resulting from the formation of a nanopore in the lipid bilayer.

8. The system of claim 7 , wherein detecting a change in the lipid bilayer electrical property comprises detecting a change in a resistance of the lipid bilayer.

9. The system of claim 7 , wherein the detection of whether a nanopore has been formed in the lipid bilayer comprises determining a number of nanopores formed based on a size of change in the lipid bilayer electrical property.

10. The system of claim 9 , wherein the processor is further programmed to control the voltage source to apply an erasing voltage stimulus waveform level to erase the lipid bilayer when it is determined that more than one nanopore are formed in the lipid bilayer.

11. The system of claim 1 , wherein the processor is further programmed to control the voltage source to apply a reverse oxidation stimulus level to the lipid bilayer after the voltage stimulus waveform is applied.

12. The system of claim 11 , wherein the voltage stimulus waveform and the reverse oxidation stimulus level comprise a positive voltage stimulus level and a negative voltage stimulus level.

13. The system of claim 1 , wherein the processor is further programmed to:

after the voltage stimulus waveform is applied, control the voltage source to apply a measuring voltage stimulus to the lipid bilayer to determine that a nanopore has been formed based on a measurement in response to the measuring voltage stimulus, wherein an absolute magnitude of the voltage stimulus waveform amplitude is different from an absolute magnitude of the measuring voltage stimulus amplitude.

14. The system of claim 1 , wherein the predetermined duration is selected such that only a single nanopore is formed in the lipid bilayer.

15. The system of claim 14 , wherein the predetermined duration is between 50 milliseconds and one second.

16. A system for forming a nanopore in a lipid bilayer, comprising:

a chamber containing a nanopore forming solution, wherein the nanopore forming solution is deposited over a lipid bilayer; and

a processor programmed to:

control a source to initiate formation of a nanopore in the lipid bilayer, wherein initiating formation of a nanopore comprises applying an agitation stimulus level of a predetermined duration to the lipid bilayer; and

after the agitation stimulus level, control the source to apply a measuring stimulus level to the lipid bilayer to determine that a nanopore has been formed based on a measurement in response to the measuring stimulus level, wherein an absolute magnitude of the agitation stimulus level is different from an absolute magnitude of the measuring stimulus level.

17. The system of claim 16 , wherein the voltage stimulus waveform has a voltage amplitude that increases over time to a predetermined magnitude.

18. The system of claim 1 , wherein the voltage stimulus waveform has a voltage amplitude that increases over time to a predetermined magnitude.

19. A system for forming a nanopore in a lipid bilayer, comprising:

a chamber containing a nanopore forming solution, wherein the nanopore forming solution is deposited over a lipid bilayer, the nanopore forming solution having a concentration level and a corresponding activity level of pore molecules such that nanopores are preferentially inserted via an active mechanism that depends on a voltage stimulus waveform applied across the lipid bilayer over a passive mechanism that depends on a self-assembly process; and

a processor programmed to:

control a voltage source to initiate formation of a nanopore in the lipid bilayer, wherein initiating formation of a nanopore comprises applying the voltage stimulus waveform to the lipid bilayer;

detect whether a nanopore has been formed in the lipid bilayer; and

in the event that a nanopore is not detected, iteratively initiate formation of a nanopore in the lipid bilayer, comprising:

controlling the voltage source to increase an amplitude of the voltage stimulus waveform applied to the lipid bilayer; and

detecting whether a nanopore has been formed in the lipid bilayer.

20. The system of claim 19 , wherein the amplitude of the voltage stimulus waveform does not exceed a predetermined amplitude.

Assignments (2)
MERGER Recorded Sep 22, 2023
From: GENIA TECHNOLOGIES, INC.
To: ROCHE SEQUENCING SOLUTIONS, INC.
Reel/Frame 064999/0989 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 5, 2019
From: CHEN, ROGER J.A.; DAVIS, RANDY
To: GENIA TECHNOLOGIES, INC.
Reel/Frame 049384/0537 →
Continuity (3)
Continuation 14150322 · Jan 8, 2014
Continuation In Part 12658591 · Feb 8, 2010
Related Publication 20170322195A1 · Nov 9, 2017